2SEVENTY BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.255 USD | -0.82% |
|
-5.86% | -0.35% |
| Apr. 19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
| Apr. 05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 4.920 | 6.000 | 12.39 |
| Spread/Res. | -13.52% | -29.08% | -65.66% |
| Spread/Supp. | +7.45% | +37.70% | +140.40% |
| Support | 3.960 | 3.090 | 1.770 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- TSVT Stock
- Charts 2seventy bio, Inc.
